149 related articles for article (PubMed ID: 12890311)
1. Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders.
Brunello N; Tascedda F
Int J Neuropsychopharmacol; 2003 Jun; 6(2):181-9. PubMed ID: 12890311
[TBL] [Abstract][Full Text] [Related]
2. Mood stabilizers: protecting the mood...protecting the brain.
Brunello N
J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
[TBL] [Abstract][Full Text] [Related]
3. [On the relevance of protein kinase C to lithium therapy in bipolar disorder].
Sela B
Harefuah; 2004 Jun; 143(6):414-6, 462. PubMed ID: 15524097
[TBL] [Abstract][Full Text] [Related]
4. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
5. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Lenox RH; McNamara RK; Watterson JM; Watson DG
J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
[TBL] [Abstract][Full Text] [Related]
6. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers.
Manji HK; Moore GJ; Chen G
Br J Psychiatry Suppl; 2001 Jun; 41():s107-19. PubMed ID: 11450170
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action.
Divish MM; Sheftel G; Boyle A; Kalasapudi VD; Papolos DF; Lachman HM
J Neurosci Res; 1991 Jan; 28(1):40-8. PubMed ID: 1674966
[TBL] [Abstract][Full Text] [Related]
8. Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo.
Chen G; Masana MI; Manji HK
Bipolar Disord; 2000 Sep; 2(3 Pt 2):217-36. PubMed ID: 11249800
[TBL] [Abstract][Full Text] [Related]
9. Overview of the mechanism of action of lithium in the brain: fifty-year update.
Lenox RH; Hahn CG
J Clin Psychiatry; 2000; 61 Suppl 9():5-15. PubMed ID: 10826655
[TBL] [Abstract][Full Text] [Related]
10. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
Watson DG; Watterson JM; Lenox RH
J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
[TBL] [Abstract][Full Text] [Related]
11. [Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder].
Einat H; Chen G; Manji H
Harefuah; 2004 Jun; 143(6):420-5, 462. PubMed ID: 15524099
[TBL] [Abstract][Full Text] [Related]
12. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
13. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
14. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
Teo R; King J; Dalton E; Ryves J; Williams RS; Harwood AJ
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1110-4. PubMed ID: 19754462
[TBL] [Abstract][Full Text] [Related]
15. Diacylglycerol kinase (DGKA) regulates the effect of the epilepsy and bipolar disorder treatment valproic acid in
Kelly E; Sharma D; Wilkinson CJ; Williams RSB
Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30135067
[TBL] [Abstract][Full Text] [Related]
16. Anti-bipolar therapy: mechanism of action of lithium.
Jope RS
Mol Psychiatry; 1999 Mar; 4(2):117-28. PubMed ID: 10208444
[TBL] [Abstract][Full Text] [Related]
17. Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes.
Stoll AL; Severus WE
Harv Rev Psychiatry; 1996; 4(2):77-89. PubMed ID: 9384977
[TBL] [Abstract][Full Text] [Related]
18. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
Gould TD; Quiroz JA; Singh J; Zarate CA; Manji HK
Mol Psychiatry; 2004 Aug; 9(8):734-55. PubMed ID: 15136794
[TBL] [Abstract][Full Text] [Related]
19. Neurobiology of lithium: an update.
Lenox RH; McNamara RK; Papke RL; Manji HK
J Clin Psychiatry; 1998; 59 Suppl 6():37-47. PubMed ID: 9674936
[TBL] [Abstract][Full Text] [Related]
20. Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy.
Manji HK; Chen G; Hsiao JK; Risby ED; Masana MI; Potter WZ
J Clin Psychiatry; 1996; 57 Suppl 13():34-46; discussion 47-8. PubMed ID: 8970503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
